Adamadle
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $341M
Investors
- 7
About Adamadle
Based in Beijing, China, and established in 2018, Adamadle is a biotechnology company focusing on clinical development and pipeline expansion of oncology products. The company has the experience and ability to R&D of innovative drugs. It won the breakthrough therapy certification issued by the China Food and Drug Administration., Ltd., Ltd. The company provides clinical development and pipeline expansion of anti-tumor drugs. The drugs include drug candidates in phase I clinical studies, and candidate compounds in preclinical and investigational new drug (IND) stages, in which c-Met target drug candidate is in the late clinical development stage.
Who invested in Adamadle
7 investors across 2 rounds
See all investors in Adamadle
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Adamadle
Who invested in Adamadle?
Adamadle has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adamadle raised?
Adamadle has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Adamadle last raise money?
Adamadle's most recent round on record is a Series B, in Dec 2023.
What does Adamadle do?
Based in Beijing, China, and established in 2018, Adamadle is a biotechnology company focusing on clinical development and pipeline expansion of oncology products.
Where is Adamadle headquartered?
Adamadle is headquartered in Beijing, China.
Which VCs invest in companies like Adamadle?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Adamadle's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Adamadle? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.